A Case Report of Chemotherapy-induced Neuropathic Pain Treated with Oriental Medicine

  • Cho, Jung-Hyo (Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Kim, Jin-Mi (Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Kim, Jin-Hee (Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Oh, Young-Seon (Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Kim, Cheol-Jung (Department of Internal Medicine, College of Oriental Medicine, Daejeon University)
  • Received : 2010.08.31
  • Accepted : 2010.10.20
  • Published : 2010.11.30

Abstract

Objective: We present a case of chemotherapy-induced neuropathic pain with the aim of driving further study evaluating the effectiveness of Oriental medical treatment on patients with neuropathic pain. Method: We prescribed Bogijetong-tang (BJT) two times a day and performed acupuncture and moxibustion once a day over one month of hospitalization. Laboratory tests were performed twice a month during this period. To evaluate the therapeutic effect, Total Symptom Score (TSS) or Visual Analog Score (VAS) was examined at intervals of 7 days. Result: Laboratory data showed no abnormal signs compared with those of initial examination. The patient's subjective symptoms were rapidly relieved within one month. Also, the sums of TSS scores (upper limbs/lower limbs) decreased from 13.64/7.32 to 3.32/3.32 points, and VAS scores (upper limbs/lower limbs) improved from 19/10 to 6/8 points. Conclusion: This case presents a possibility that Oriental medical treatment may offer potential benefits (from an approach aimed at relieving of pain) for patients with chemotherapy-induced neuropathic pain.

Keywords

References

  1. Armstrong T, Gilbert MR. The Female Patient: Chemotherapy-induced peripheral neuropathy. Chatham, Ob/Gyn ed. 2002; 27-30.2.
  2. Ro LS, Chang KH. Neuropathic pain: mechanisms and treatments. Chang Gung Med J. 2005; 28(9):597-605.
  3. Quasthoff S, Hartung HP. Chemotherapyinduced peripheral neuropathy. J Neurol. 2002; 249:9-17. https://doi.org/10.1007/PL00007853
  4. Kim JM, Cho CS, Kim CJ. Clinical Study of 8 Diabetic Patients with Paresthesia. J Orient Int Med. 2010; 31(2):372-379.
  5. Ozdogan M, Samur M, Bozcuk H, Aydin H, Çoban E, Savas B. Venlafaxine for treatment of chemotherapy-induced neuropathic pain. Turkish Journal of Cancer. 2004; 34(3):110-113.
  6. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 1994; 35(3):304-311. https://doi.org/10.1002/ana.410350310
  7. Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997; 35(1):47-53. https://doi.org/10.1023/A:1005805907311
  8. Available from URL:http://www.cancersupportivecare.com/nervepain.php
  9. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001; 13:31-41. https://doi.org/10.3109/10401230109147127
  10. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999; 159:1931-7. https://doi.org/10.1001/archinte.159.16.1931